Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FSYY6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,799
Award facts
- Contract value 100% obligated
- $10,799.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on February 2, 2026, for RINVOQ ER 15 mg tablets in a 30-count unit dose package, with an order ceiling value of $10,799.07 and a firm fixed price structure. This is a non-set-aside, competitively awarded delivery order with a completion date of February 3, 2026, and performance to be executed at the awardee's Conshohocken, Pennsylvania facility. RINVOQ (upadacitinib) is a Janus kinase inhibitor indicated for the treatment of rheumatoid arthritis and other inflammatory conditions, making this a pharmaceutical supply contract supporting military healthcare needs.
This delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as the company's primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. As a leading pharmaceutical distributor and critical vendor in the federal medical procurement supply chain, AmerisourceBergen regularly fulfills orders for specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains for the Defense Health Agency and related military healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FSYY6?
SPE2DR26FSYY6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 2, 2026.
How much is contract SPE2DR26FSYY6 worth?
The government has obligated $10,799 on SPE2DR26FSYY6.
Is contract SPE2DR26FSYY6 an order under another contract?
Yes. SPE2DR26FSYY6 is a delivery order under SPE2DR25D1004, an indefinite delivery contract.
Was contract SPE2DR26FSYY6 competed?
The extent of competition for SPE2DR26FSYY6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award